Sysmex's History (Timeline)
1960
May.
- Taro Nakatani, then-vice president of leading megaphone manufacturer TOA ELECTRIC CO., LTD. (presently TOA Corporation), traveled to the United States in search of a new pillar of business
1961
Jun.
- TOA ELECTRIC CO., LTD. (presently TOA CORPORATION) entered the medical electronics market. The company founded a new laboratory, where three engineers began research in this field
1963
Dec.
- Successfully commercialized the automated hematology analyzer, the first blood cell counter in Japan
(CC-1001 automated hematology analyzer)
1965
Jan.
- Founder Taro Nakatani announced the corporate attitude of “selling the results”
1966
Jan.
- Launched the CC-1002 automated hematology analyzer
- The company began publishing MCC News for hospital laboratories around Japan (MCC is an acronym for “micro cell counter”)
1967
Jul.
Saponin S, a lysing reagent
- Launched Cellkit, a diluent solution, and Saponin S, a hemolytic agent. These were the first reagents developed by an electrical equipment manufacturer
Dec.
- TOA ELECTRIC CO., LTD., launched the ME Instrument Department
(ME stands for “medical electronic instruments”)
1968
Jan.
- The Company formulated “Basics of Our Company Management,” summarizing fundamental management perspectives and action guidelines
Feb.
- TOA MEDICAL ELECTRONICS CO., LTD. was founded to sell medical electronic equipment manufactured by TOA ELECTRIC CO., LTD. Taro Nakatani was appointed as the first president
Apr.
- The Company began selling CELLCHECK-B, a standard reference substance that includes a defined number of blood cells, allowing laboratories to confirm the accuracy of their cell measurements
1972
Feb.
- Acquired the Medical Electronics (ME) Equipment Division of TOA ELECTRIC CO., LTD.
- Establishment of the first overseas location (Germany)
1973
Jun.
- The Company established the Kakogawa Factory and integrated the Sales, Development, Production and General Affairs divisions
1974
Mar.
- Taro Nakatani addressed all employees, emphasizing that “Quality is our heart: the company's means to life”
Sep.
- The Company launched the TU-100, a simplified automated urinalysis analyzer, marking its entry into the urinalysis field
1975
Oct.
- Launched the first fully automated hematology analyzer developed in Japan
(The automated hematology analyzer CC-710)
1977
Jul.
- Start of entry into the United States market
1978
Feb.
- The birth of the Sysmex brand
The product brand transitions from TOA to Sysmex
May.
- Holding of the first Sysmex hematology seminar
1979
Mar.
- The Company launched the world’s first fully automatic blood cell counter featuring a sampler, the CC-720
Oct.
- The Company established TOA MEDICAL ELECTRONICS (USA) INC. (presently Sysmex America, Inc.)
1980
Oct.
- The Company established TOA MEDICAL ELECTRONICS (DEUTSCHLAND) GMBH (presently Sysmex Europe SE)
- Launched a multi-parameter fully automated hematology analyzer, the E-series
1984
Jan.
- The Company launched the CA-100, the automated blood coagulation analyzer
1985
Sep.
- Launched the CA-3000 fully automated blood coagulation analyzer. Employing robotics concepts, the new instrument enabled random processing for each specimen
1986
Apr.
- Established the Kobe Factory in Seishin Industrial Park, Nishi-ku, Kobe, and relocated the Techno Center (presently Technopark)
1987
Mar.
- The Company launched the PAMIA-10 immunochemical analyzer, which used a proprietary immunoassay method to measure tiny amounts of protein in serum, marking its entry into the immunochemistry field
1988
May.
- Reizo Hashimoto was appointed president, stated “Within 10 years, we will become the global leader in the hematology field.” and “We aim for new business to account for more than 40% of sales”
Aug.
- The Company launched the automated reticulocyte analyzer R-1000, the world’s first instrument to automatically measure reticulocytes
Sep.
- Launched the NE-8000 automated hematology analyzer, enabling simultaneous blood cell counting and white blood cell differentiation and employing thorough biohazard measures
1989
May.
- Relocated the headquarters to Chuo-ku, Kobe, and integrated all headquarters functions as the Sales and Trade Divisions
1990
Aug.
- The Company launched the HS-Series integrated hematology system, the world’s first fully automated system handling blood cell counts, white blood cell differentiation, reticulocyte measurement and preparation of smear samples
Sep.
- The Company launched the automated urine sediment analyzer UA-1000, marking its entry into the sediment urinalysis field with products developed in-house
1991
Feb.
- Established of our first reagent factory in Japan, Ono Factory in Ono, Hyogo Prefecture and relocated the Reagent Production Division
May.
- Commencement of direct sales, service and support for the first time overseas (United Kingdom)
The Company established its first overseas sales subsidiary, TOA MEDICAL ELECTRONICS (UK) LTD. (presently Sysmex UK Limited)
1992
Jul.
- Established Sysmex TMC Co., Ltd.
1993
Jul.
- Completed construction of the Neumünster Factory to serve as the reagent production base for Europe
Dec.
- Established the U.S. subsidiary SYSMEX CORPORATION (presently Sysmex Reagents America, Inc.)
- Launched the SE-9000 automated hematology analyzer
1994
Oct.
- Start of developing an operating base in the Asia Pacific region
The Company established the Singapore representative office
1995
Mar.
- Established a German subsidiary SYSMEX GMBH DEUTSCHLAND (presently Sysmex Deutschland GmbH)
- Concluded a business collaboration agreement with Dade International Inc. (presently Siemens Healthcare Diagnostics Inc.) for coagulation product lines
Jun.
- Establishment of a reagent supply and technical service structure in China
The Company established a joint venture (presently Jinan Sysmex Medical Electronics Co., Ltd.) in China
Jul.
- Obtained ISO 9001 certification, ensuring global standards in quality assurance
Sep.
- Launch of the SF-3000 automated multiparameter hematology analyzer, combining a semiconductor laser and flow cytometry technology
The Company promoted the spread of white cell differentiation instruments among small and medium-sized laboratories
Oct.
- The Company launched a laboratory information system
Nov.
- Listed on the Second Section of the Osaka Securities Exchange
- Launched the UF-100, the world's first analyzer of tangible constituents of urine, with fully automated inspections of urinary sediments
1996
Jul.
- Listed on the Second Section of the Tokyo Stock Exchange
- Hisashi Ietsugu (current Chairperson and Group CEO) appointed president and stated “We aim to transform the Company from a specialized manufacturer to a distinctive and global comprehensive manufacturer”
1997
Feb.
- Established the U.S. subsidiary SYSMEX INFOSYSTEMS AMERICA, INC. (presently Sysmex America, Inc.)
1998
Feb.
- Establishment of SYSMEX SINGAPORE PTE LTD. (presently Sysmex Asia Pacific Pte Ltd.), as a regional headquarters for the Asia Pacific region
Apr.
- Established the Malaysian subsidiary Sysmex (Malaysia) Sdn Bhd.
May.
- Signed a basic agreement for a global alliance concerning marketing and joint research and development with F. Hoffmann-La Roche, Ltd.
Jul.
- Established the joint venture SYSMEX TRANSASIA BIO-MEDICALS PRIVATE LTD. (presently Sysmex India Pvt. Ltd.)
- Obtained ISO 13485 certification, a global standard in quality assurance of medical devices, and EN 46001, a similar European standard
Oct.
- Changed the company name to Sysmex Corporation, and relocated the head office to the east of Kobe
Dec.
- Established the Brazilian subsidiary Sysmex Do Brasil Industria e Comercio Ltda.
1999
Jan.
- Launch of the XE-2100 automated multiparameter hematology analyzer, achieving personnel savings and higher efficiencies in testing operations
Apr.
- Launched the world's first peripheral blood vessel monitoring device, ASTRIM
Jul.
- Established the Thai subsidiary Sysmex (Thailand) Co., Ltd.
Dec.
- Established the Hong Kong subsidiary Sysmex Hong Kong Limited
- The Company began providing Sysmex Network Communication Systems (SNCS), an online support service
2000
Jan.
- Established the Chinese subsidiary Sysmex Shanghai Ltd. in Shanghai
Feb.
- The Company began producing reagents at subsidiaries in Brazil
Mar.
- Promoted to the First Section of the Tokyo Stock Exchange and the Osaka Securities Exchange
- Established the French subsidiary SYSMEX FRANCE S.A.R.L. (presently Sysmex France S.A.S.)
Apr.
- Established the Central Research Laboratories in the Techno Center (presently Technopark)
- The Kakogawa Factory obtained ISO 14001 certification for its global standard of environmental management
May.
- Established the Taiwanese subsidiary Sysmex San Tung Co., Ltd. (presently Sysmex TAIWAN Co., Ltd.)
Oct.
- The Company began producing reagents at subsidiaries in Singapore
2001
Mar.
- Established the African Service Center to provide technical services in Africa
Sep.
- Launched the PAMIA-40i immunoagglutination analyzer, which reduces testing time by two-thirds through whole blood testing
Oct.
- Acquired Delphic Medical Systems and changed its name to Sysmex Delphic Limited (presently Sysmex New Zealand Limited)
2002
Mar.
- Established the Indonesian subsidiary PT. Sysmex Indonesia
Apr.
- International Reagents Corporation became a wholly owned subsidiary (Absorbed into Sysmex Corporation in 2022)
May.
- Developed genetic testing technology that can detect cancer cell metastasis in lymph nodes within 15 minutes
Oct.
- RA SYSTEMS CORPORATION (presently Sysmex RA Co., Ltd.) became a subsidiary
2003
Jun.
- Commencement of direct sales and service in the United States
Merged two U.S. subsidiaries, SYSMEX CORPORATION OF AMERICA and SYSMEX INFOSYSTEMS AMERICA, INC., to establish Sysmex America, Inc.
Aug.
- Established the Chinese subsidiary Sysmex Wuxi Co., Ltd. (the second reagent factory) in Jiangsu
Oct.
- The ASTRIM SU peripheral blood vessel monitoring system was awarded the Good Design Award
Dec.
- SYSMEX DELPHIC LIMITED (presently Sysmex New Zealand Limited) became a subsidiary
2004
Apr.
- CNA CO., LTD. (presently Sysmex CNA Co., Ltd.) became a subsidiary
- Sysmex’s immature cell measuring reagent technology was awarded an Honorable Mention under the National Commendation for Invention in 2004
Jun.
- Established research and development bases at the Business Support Center for Biomedical Research Activities (BMA) on Port Island Second Stage, on Port Island in Kobe
2005
Apr.
- Established the Polish subsidiary Sysmex Polska Sp.z.o.o.
May.
- Established the Solution Center in Nishi-ku, Kobe
Nov.
- Carried out a two-for-one stock split
Dec.
- Established Sysmex Women’s Track & Field Team
2006
Jan.
- Launched a high-performance, compact automated hematology analyzer, the XS-Series
Apr.
Right: LYNOAMP BC
- In Europe, Sysmex launched its first product in the life science business: the RD-100i gene amplification detector and LYNOAMP BC, a related reagent
May.
- Established the South Africa subsidiary Sysmex South Africa (Pty) Ltd.
Jul.
- Opened R&D Center Europe in Germany
Aug.
- Launched the in vitro diagnostics industry's first coagulation analyzer with a multi-wavelength pre-analytical check, the CS-2000i
Sep.
- Established the Swiss subsidiary Sysmex Digitana AG (presently Sysmex Suisse AG)
Dec.
- Entered into agreements for joint R&D, clinical development and marketing with Affymetrix, a U.S. company that manufactures genetic analysis systems for life science research and clinical healthcare
2007
Apr.
- Formulated the Sysmex Group corporate philosophy, the “Sysmex Way”
- Established the Tokyo Office and the Metropolitan Area Service Center
May.
- Launched a rapid respiratory infection diagnosis kit, POCTEM S Series
Sep.
- Established the Austrian subsidiary Sysmex Austria GmbH
- Established the Slovak subsidiary Sysmex Slovakia s.r.o.
- Launched the XE-5000 automated hematology analyzer
Oct.
- Established the Hungarian subsidiary Sysmex Hungaria Kft
- Established the Canadian subsidiary Sysmex Canada, Inc.
- Established the Czech subsidiary SYSMEX CESKA REPUBLIKA S.R.O. (presently Sysmex CZ s.r.o.)
- Released the HISCL-2000i, a fully automated immunoassay analyzer enabling highly sensitive, high-speed assay
2008
Jun.
- Launched the RD-100i breast cancer lymph-node metastasis rapid diagnosis system, the first instrument in Japan to automate the testing of breast cancer lymph node metastasis
- Established the Dubai subsidiary Sysmex Middle East FZ-LLC
Oct.
- Redesigned the corporate logo on the occasion of the 40th anniversary of the Company’s establishment
- Established Technopark, Sysmex's research and development headquarters, doubling the size of the previous Techno Centre facilities
Dec.
- Launched POCTEM Avian Influenza, Japan’s first rapid influenza diagnostic kit for chickens
2009
Jan.
- Established the Indian joint venture Sysmex Transasia Services Pvt Ltd.
Feb.
- Joint development, with the Osaka Prefectural Institute of Public Health, of technology to detect the avian influenza virus easily and quickly
- Launched the XT-4000i, a new model in the XT-Series of hematology analyzers
Apr.
- Opened the Sysmex Kids Park, an in-house daycare center at Technopark
- Established the Dutch subsidiary Sysmex Nederland B.V.
- Established the Belgian subsidiary Sysmex Belgium B.V.
Dec.
- Opened the Diagnostic Reagent Development Center in Wuxi, China
2010
Jan.
- Established a German subsidiary, HITADO GmbH, specializing in the sales and support of POCT products
- Established a Spanish subsidiary, Sysmex Espana S.L.
Mar.
- Established a Vietnamese subsidiary, Sysmex Vietnam Company Limited
Apr.
- Established the Group's Long-Term Environmental Objectives
Jun.
- Received an Invention Award for developing a reagent to analyze formed elements in urine, from the 2010 National Commendation
Jul.
- Launched joint business with IDEXX, a leader in pet diagnostics
Aug.
- Announced business collaboration with Malvern Instruments
Sep.
- Established a Philippines subsidiary, Sysmex Philippines Inc.
Oct.
- Received the Fiscal 2010 Intellectual Property Achievement Award from the Ministry of Economy, Trade and Industry Patent Office
- HYPHEN BioMed, SAS became a subsidiary
Dec.
- Launched the world's first fully-automated integrated urine analyzer, the UX-2000, jointly developed with ARKRAY
- Launched the PROWELL Opti Health Guidance Optimization Service, an SaaS Service to help manage employee health
- Became the first in the world to automate testing of colon cancer lymph node metastasis
2011
Jan.
- Established a Russian subsidiary, Sysmex RUS LLC
Mar.
- Joined the United Nations Global Compact
Apr.
- Carried out a two-for-one stock split
- Acquired Katakura Industries Co., Ltd.'s Research Institute of Biological Science
May.
- Launched the XN-Series, our new model in the hematology field
- Received the Invention Award in the 2011 National Commendation for Invention, for technologies related to our white blood cell classification method and reagents
Jul.
- Launched a new model in the hemostasis field, the CS-5100™ automated blood coagulation analyzer
Nov.
- The Sysmex Reference Counter was employed as a national standard for blood cell counting in China
- Our in vitro diagnostic system using the design concept "Silent Design®" was awarded a Good Design Gold Award 2011
- Sysmex was the Special Sponsor of the Kobe Marathon 2011
2012
Jan.
- Began offering laboratory testing services for research involving the risk of recurrence of early-stage breast cancer
May.
- Launched the compact XP-Series in the hematology field
Aug.
- Succeeded in automating rapid detection of lymph node metastasis in stomach cancer
Oct.
- Established a protein production center in Nishi-ku, Kobe
Dec.
- Launched the HISCL®-5000, a new automated immunoassay system for immunochemistry testing
2013
Jan.
- XN-2000 and XN reagents received Germany’s iF Product Design Award 2013
Apr.
- Established Sysmex Business Support Co., Ltd.
- The Sysmex Women's Track & Field Team relocated its training base to Kobe
- Established a South Korean subsidiary, Sysmex Korea Co., Ltd.
- "Development of a Method of Classifying and Counting Particles for Automated Hematology Analyzers" awarded the Fiscal 2013 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology
May.
- Established the “Sysmex Forest” in Ono, Hyogo Prefecture
Jul.
- Opened the R&D Center Americas in the United States
Aug.
- Established a Turkish subsidiary, Sysmex Turkey Diagnostik Sistemleri Ltd. Sti.
- Established Medicaroid Corporation, a marketing company for the development of medical robots, jointly with Kawasaki Heavy Industries, Ltd.
Sep.
- Partec GmbH (presently Sysmex Partec GmbH) became a subsidiary
Oct.
- Inostics GmbH (presently Sysmex Inostics GmbH) became a subsidiary
- The ASTRIM FIT health monitoring analyzer was awarded a Good Design Award
Dec.
- The XN-2000 and XN reagents received the German Design Award
- Succeeded in the world's first practical application of technology employing a glycosylation marker to test for hepatic fibrosis, resulting in the HISCL™ M2BPGi™ Assay Kit
2014
Mar.
- Accredited as an ISO/IEC 17025 and ISO/IEC 17043 Calibration Laboratory and Proficiency Testing Provider
Apr.
- Carried out a two-for-one stock split
- Established Sysmex Engineering Co., Ltd.
- Established a Colombian subsidiary, Sysmex Colombia SAS
- "Development of a Method for Analyzing Formed Elements in Urine" awarded the Fiscal 2014 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology
Jun.
- Equity participation in Riken Genesis Co., Ltd., a subsidiary of Toppan Printing Co., Ltd., for the purpose of developing a genetic testing business in personalized medicine
- Opened i-Square, an instrument factory in the city of Kakogawa
Aug.
- Our CC-1001, the first commercialized automated hematology analyzer in Japan, was certified under the 3rd Heritage Program of Legacy Analytical Instruments/Scientific Instruments
Sep.
- Launched the HISCL™-800, a new compact automated immunoassay system for immunochemistry testing
Oct.
- Launched the CS-2400/2500, a new automated blood coagulation analyzer
Nov.
- Established an Australian subsidiary, Sysmex Australia Pty Ltd.
Dec.
- Established a new Japanese base within IMP on Kobe Port Island to develop companion diagnostics drugs toward the realization of personalized medicine
2015
Jan.
- Launched the XN-L series, a new compact model in the XN family of automated hematology analyzers
- Launched the CS-1600, a compact new automated blood coagulation analyzer model in the hemostasis field
Mar.
- Invested in iPS PORTAL, Inc., aiming to contribute to regenerative medicine
Apr.
- Established the Global Communication Center as a place to facilitate unfettered communication and prompt ideas
May.
- Received accreditation under ISO 15195 “Laboratory medicine - requirements for reference measurement laboratories”
Jun.
- Announced strategic collaboration with LabCorp for blood-based molecular testing services and products to support the development of precision medicine in oncology
Sep.
- Launched the UF-5000/4000/3000, fully-automated analyzers of formed elements in urine, the next-generation models in the sediment urinalysis testing field
Oct.
- Opened the Sysmex Open Innovation Lab in Technopark
Nov.
- Received the 20th “IR Grand Prix Award” from the Japan Investor Relations Association
- Opened a lab within the National Cancer Center to promote the development of new cancer diagnosis methods
Dec.
- Established a Ghanaian subsidiary, Sysmex West and Central Africa Ltd.
2016
Jan.
- Launched the UC-3500, fully-automated urine chemistry analyzer and the first product in the field of urine qualitative analysis in overseas markets
- Launched a new product in the sediment urinalysis testing field, the UD-10 fully-automated imaging unit for formed elements in urine
Jun.
- Converted RIKEN GENESIS Co., Ltd. to a subsidiary to promote the development of a genetic testing business in the area of personalized medicine
Aug.
- Received the 14th Annual Merit Award from the Minister of Economy, Trade and Industry for collaborative achievement between industry, academia and government
Sep.
- Automated blood coagulation analyzer CA-100 certified under the 5th Heritage Program of Legacy Analytical Instruments/Scientific Instruments
- Selected for inclusion in the Dow Jones Sustainability World Index for the first time
- Received “Eruboshi” certification as an excellent company based on the Act on Promotion of Women’s Participation and Advancement in the Workplace
2017
Apr.
- Established Sysmex Harmony Co., Ltd., to promote the employment of people with disabilities
- Received an award for science and technology for our development of white blood cell five-part differentiation and an atypical white blood cell differentiation method, from the 2017 National Commendation
May.
- Received an Invention Award for hematology analyzers that enables the rapid evaluation of the effects of administering iron preparations, from the 2017 National Commendation
- Oxford Gene Technology IP Limited became a subsidiary
Jun.
- Opened a new R&D facility Skyfront Research Campus in Kawasaki city
- Entered into a comprehensive collaboration agreement with RIKEN GENESIS Co., Ltd. and MITSUI KNOWLEDGE INDUSTRY CO., LTD.
Jul.
- Expanded Sysmex Reagents of America’s reagent factory in illinois, the United States
Sep.
- Entered into an agreement with Mongolia’s Ministry of Health to provide technological and scientific support and external quality assessment support
Oct.
- Signed affiliation agreements with figure skaters Mai Mihara and Kaori Sakamoto
Nov.
- Received "a CLIA-waiver" certification under the US regulatory approval system for the XW-100 automated hematology analyzer
2018
Mar.
- Launched the automated high-sensitive immunoassay system for research applications HI-1000
Apr.
- Launched a new network solution "Caresphere™" to provide new value through the intelligent use of information by people involved in testing and healthcare
- Obtained an ISO Guide 34 general requirements for the competence of reference material producers
May.
- Launched the Gene Amplification Detector RD-200 and the LYNOAMP™CK19 gene-amplification reagent, for the rapid detection of cancer lymph node metastasis using the OSNA™ method
Jul.
- Established an Egyptian subsidiary, Sysmex Egypt LLC
Aug.
- Opened the Center for Learning, expanding training facilities for customers in North America
Oct.
- Opened the Sysmex R&D Center Europe GmbH
Nov.
- Launched the Single Molecule Fluorescence Microscope HM-1000 for Research Use
Dec.
- Launched our next-generation analyzers in the hemostasis field, the Automated Blood Coagulation Analyzers CN-6000 and CN-3000
- Launched the Imaging Flow Cytometer MI-1000 and related software MI FISH Master as a system
2019
Feb.
- Launched assay service using the OncoGuide™ NCC Oncopanel System in cancer genome profiling
Apr.
- Obtained CE Certification for the automated hematology analyzer XN-31, which has an automatic measurement function for red blood cells infected by Malaria Parasites
May.
- Opened Technopark East Site, a bio-diagnostic reagent base located within Technopark in Kobe
Jun.
- The World Anti-Doping Agency has coordinated the simultaneous introduction of Sysmex’s XN-Series automated hematology analyzers at all WADA-accredited and approved laboratories throughout the world
Jul.
- "Hepatic fibrosis diagnostic technology using a new glycosylation marker" was awarded the 44th Inoue Harushige Prize
Aug.
- Obtained first manufacturing and marketing approval in Japan for blood-based RAS gene mutation testing for colorectal cancer
Sep.
- Japan’s first automated hematology analyzer CC-1001 registered by the National Museum of Nature and Science as "Essential Historical Material for Science and Technology"
- Developed a fully automated measurement method for soluble immune checkpoint molecules (sPD-1, sPD-L1 and sCTLA-4) through joint R&D with Kyoto University
2020
Mar.
- Obtained first marketing approval in Japan for an in vitro diagnostic medical device, “2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit“
Apr.
- Formulated the Sysmex declaration of a healthy company, “United In Sound Health“
Jun.
- Configured and began a PCR testing system within the Kobe Biomedical Innovation Cluster for the COVID-19 with the City of Kobe and SRL, Inc.
- Jointly established D’PULA Medical Solutions Corporation with OPTiM Corporation
Sep.
- “Invention of a urine sample analyzer useful for the early detection of disease“ awarded the Fiscal 2020 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology
- Certified under the JICA-SDGs partner through dissemination of automated urinalysis diagnosis technology in the Republic of Ghana
Dec.
- Launched the hinotori Surgical Robot System, a surgical robot unit
2021
Feb.
- Established a Portuguese subsidiary, Sysmex Portugal, S.A.
Mar.
- Launched our next-generation flagship model in the hematology field, the XR-Series Automated Hematology Analyzer, and a compact 3-part WBC differential model, the XQ-Series Automated Hematology Analyzer
May.
- Entered into joint development and investment agreements for the commercialization of an AI-based cell analysis technology with ThinkCyte, Inc.
- Received an Invention Award for invention of multi-modularization of blood cell analyzer for improving test speed, from the 2021 National Commendation
Oct.
- Applicated for selection of new market segment “Prime Market“ on the Tokyo Stock Exchange
2022
Feb.
- Established a Saudi Arabian subsidiary, Sysmex LLC
- Formed a capital and business tie-up with KAINOS Laboratories in the immunochemistry field
Apr.
- Sysmex sponsored as a silver partner of Amplification of Lives, a thematic project which is a key feature of the 2025 World Exposition in Japan (the Expo 2025 Osaka)
May.
- Sysmex Astrego AB became a subsidiary
- Set “Carbon Neutral Targets“ to realize zero greenhouse gas emissions in real terms by 2040
Jun.
- Received an Invention Award for invention of rapid accurate method for measuring platelets using dye for platelets, from the 2022 National Commendation
Jul.
- Launched new sample transportation system modules that can be connected to the XR-Series Automated Hematology Analyzer, our flagship models in the hematology field
Aug.
- Pilot, Inc. became a subsidiary
Sep.
- Launched the UF-1500 Fully Automated Urine Particle Analyzer, a new product for use in urine sediment testing
Oct.
- Established a joint venture AlliedCel with the co-founder JCR Pharmaceuticals Co., Ltd.
2023
Mar.
- Entered into a global OEM agreement on hemostasis products with Siemens Healthcare Diagnostics Inc.
May.
- Launched clinical flow cytometry system in Japan
Jun.
- Obtained first manufacturing and marketing approval in Japan for PrismGuide™ IRD Panel System as Japan’s first gene panel testing system for inherited retinal dystrophy
- Launched the HISCL β-Amyloid 1-42 Assay Kit and the HISCL β-Amyloid 1-40 Assay Kit in Japan to measure amyloid β in the blood
- Launched PA-100 AST System, the world's first testing system in Europe to detect antimicrobial susceptibility in just 30 minutes
Oct.
- Entered into basic agreement on business collaboration in the field of immunoassay with Fujirebio
- Established the new open innovation hub “Healthcare Science Hub Tokyo“
- Obtained an ISO 304141 certification Human Capital Reporting, as the first such certification that has been granted for the manufacturing industry in Asia
Dec.
- Megakaryon Corporation became a subsidiary
2024
Feb.
- Carried out a two-for-one stock split
Apr.
- Began selling hemostasis instruments and reagents under the Sysmex brand in the United States and EU countries
- Received an Award for Science and Technology for our development of white blood cell five-part differentiation and an atypical white blood cell differentiation method, from the 2024 National Commendation
Jun.
- PA-100 AST System for rapid detection of antimicrobial susceptibility won one of the UK’s biggest science prizes “Longitude Prize on AMR“
Jul.
- Established a diagnostic reagents and instrument manufacturing base in Gujarat, India
Aug.
- Expanded strategic alliance agreement with QIAGEN in the field of genetic testing
2025
Jan.
- Became the first in the industry to launch reagents using closed-loop recycled container in Japan
Mar.
- Relocated and expanded the Sysmex RA factory in Shiojiri City, Nagano Prefecture
- Established a Kenya subsidiary, Sysmex East Africa Ltd.
Jun.
- Established a Greece subsidiary, Sysmex Greece I.K.E.